Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
Acq. announced
Director departure
CC transcript
MGI PHARMA INC (MOGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2007 8-K/A Cost Associated with Exit or Disposal Activities
02/09/2006 8-K/A Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORRECTING AND REPLACING: MGI PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2005 FINANCIAL RESULTS"
11/07/2005 8-K/A Financial Statements and Exhibits
Docs: "Consent of KPMG LLP",
"Audited consolidated financial statements of Guilford, including Guilford's consolidated balance sheets as of December 31, 2004 and 2003, the consolidated statements of operations, changes in stockholders' equity and cash flows for each of the years in the three year period ended December 31, 2004",
"Unaudited condensed consolidated financial statements of Guilford, including Guilford's consolidated balance sheet as of June 30, 2005, the consolidated statements of operations, changes in stockholders' equity and cash flows for the six month period ended June 30, 2005",
"Unaudited pro forma condensed combined financial statements of the Company as of and for the six months ended June 30, 2005 and for the year ended December 31, 2004"
12/14/2004 8-K/A Financial Statements and Exhibits
Docs: "Consent of Ernst & Young LLP",
"Audited financial statements of Aesgen, Inc. for the years ended December 31, 2002 and 2003 and unaudited financial statements of Aesgen, Inc. for the six months ended June 30, 2004"
11/19/2004 8-K/A Financial Statements and Exhibits
Docs: "Consent of Ernst & Young LLP",
"Audited consolidated financial statements of Zycos, Inc. for the year ended December 31, 2003 and unaudited consolidated financial statements of Zycos, Inc. for the six months ended June 30, 2004"
08/27/2004 8-K/A Other Events, Financial Statements and Exhibits
Docs: "*Amendment No. 1 to the License Agreement, between Helsinn Healthcare SA and MGI PHARMA, INC",
"*Amendment No. 2 to the License Agreement, between Helsinn Healthcare SA and MGI PHARMA, INC",
"*Amendment No. 1 to the Supply and Purchase Agreement, between Helsinn Birex Pharmaceuticals Ltd. and MGI PHARMA, INC"
02/05/2001 8-K/A Financial statements and exhibits
Docs: "Consent of KPMG LLP",
"Independent Auditors' Report and Financial Statements of The Hexalen(R) Business of MedImmune, Inc",
"Unaudited Pro Forma Financial Statements of MGI PHARMA, Inc. -2-"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy